MARKET

DXCM

DXCM

Dexcom Inc
NASDAQ
62.80
+0.90
+1.45%
Pre Market: 62.91 +0.11 +0.18% 04:01 04/01 EDT
OPEN
62.77
PREV CLOSE
61.90
HIGH
63.68
LOW
61.96
VOLUME
4
TURNOVER
--
52 WEEK HIGH
89.98
52 WEEK LOW
54.11
MARKET CAP
24.17B
P/E (TTM)
30.45
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DXCM last week (0323-0327)?
Weekly Report · 2d ago
Notable healthcare headlines for the week: Merck, Medtronic, and Novartis in focus
Seeking Alpha · 2d ago
DexCom Inc. Stock Falls 5.8%, Underperforms Peers
Dow Jones · 4d ago
DexCom Inc. stock underperforms Friday when compared to competitors
MarketWatch · 4d ago
GlucoTrack Stock Gains As Data Backs FDA Filing Plans For Glucose Monitoring Tech
Benzinga · 4d ago
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know
Barchart · 4d ago
BUZZ-U.S. STOCKS ON THE MOVE-FedEx, Estee Lauder, Janus Henderson
Reuters · 03/24 16:09
BUZZ-U.S. STOCKS ON THE MOVE-DexCom, Ocugen, Estee Lauder
Reuters · 03/24 13:10
More
About DXCM
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. It enables people to take control of health through innovative biosensing technology. The G7 is an integrated continuous glucose monitoring system. Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes. The G7 and G7 15 Day includes finger stick elimination, continuous glucose readings and others.

Webull offers DexCom Inc stock information, including NASDAQ: DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXCM stock methods without spending real money on the virtual paper trading platform.